NOTE: Gilead accepts grant applications year-round, meaning your organization may apply whenever you’re ready. Keep in mind that you must submit the application at least 6 weeks before your activity begins, and that it typically takes about 6 to 12 weeks for us to review it. 

Types of Organizations We Support

Patient Community Support

Lack of awareness is often a significant barrier to disease screening and treatment — especially among at-risk populations — leading to acute disparities in care. Gilead supports patients and their communities by funding a variety of awareness-raising projects.

Examples of Patient Community Support projects Gilead has funded include:

• Events or resources to educate patients about prevention and care options, such as:
  • Presentations
  • Web-based resources
  • Printed materials
  • Testing and screening initiatives
• The types of Patient Community Support organizations Gilead has funded include:
  • Patient advocacy and support groups
  • Hospitals and clinics
  • Nonprofit service organizations
  • Professional associations
  • Academic medical centers and universities

Medical & Scientific Support

Ongoing education is essential to ensuring that healthcare professionals can continue to deliver the best possible care based on the latest advances in medicine. Gilead supports high-impact, continuing medical education programs that expand the knowledge and skills of healthcare professionals.

Gilead has funded a range of Medical and Scientific Support projects, including:

• Continuing medical education (CME) accredited by ACCME or another relevant organization
• Non-accredited CME in compliance with FDA guidelines
• Scientific conferences
• Lecture series or symposia

The types of Medical and Scientific Support organizations Gilead has funded include:

• Medical universities
• Professional associations
• Community health centers
• Hospitals and academic medical centers

Gilead North America Grants

Gilead is inspired by the work that our grantees do every day to improve access and eliminate barriers to healthcare, and advance education among patients and healthcare professionals. Gilead supports projects across all of our therapeutic areas — HIV, liver diseases, hematology and oncology, and inflammatory and respiratory diseases.

HIV

Continual advances in medical research help millions of people living with HIV have longer, more fulfilling lives today. But HIV continues to have a devastating impact, especially on people who belong to underserved communities and who lack access to medical care. Gilead supports organizations working to help individuals learn their status and get the care they need. We also support organizations that aim to solve the challenges of tomorrow, including how to:

• Understand the impact HIV has on an aging population
• Ensure continuity and retention in care
• Spark appreciation for innovative thinking in HIV treatment
• Identify and create a new generation of advocates

HIV Cure

Gilead works to address the HIV epidemic by discovering transformative and life-saving medicines, developing simplified treatment regimens that increase efficacy, expanding access to treatment for those who need it most and building communities among people affected by HIV and AIDS. Continuing on this commitment, Gilead will partner with and support institutions, community groups and organizations that are engaged in HIV cure activities by providing grant funding.

HIV Prevention

More tools than ever are now available to help prevent HIV infection. Yet about 40,000 new cases of HIV are still reported in the U.S. each year. Gilead supports the efforts of community-based organizations, public health entities and similar nonprofit organizations to educate their constituents about comprehensive HIV prevention, including the role of pre-exposure prophylaxis (PrEP). Specifically, Gilead supports programs designed to:

• Provide comprehensive education on the range of prevention options and strategies available
• Ensure biomedical prevention plans, such as PrEP, are implemented safely and effectively in accordance with recommended guidelines
• Engage communities and individuals at highest risk for HIV infection in prevention efforts

Liver Disease

Each year, more Americans die from Hepatitis C than HIV. Yet public awareness of this disease remains limited because of its disproportionate impact on drug users, minorities and other at-risk groups. Gilead is working to change this by funding organizations that raise awareness of the importance of testing and access to care among these groups, as well as those that:

• Look for ways to increase treatment capacity and sustainability
• Move individuals down the care pathway from screening to cure
• Eliminate intrinsic barriers to care and treatment

Oncology:

Cancer remains one of the greatest health challenges we face. While the search for a cure continues, education and awareness are powerful tools to support diagnosis and treatment. Gilead supports organizations focused on health equity in order to:

• Enable people affected by cancer and their caregivers to make informed health decisions
• Educate healthcare providers on identification, screening and diagnosis
• Improve access to prevention and treatment by overcoming barriers to care

Inflammatory and Respiratory Diseases:

From cystic fibrosis (CF) to influenza, inflammatory and respiratory diseases have a substantial impact on people of every age, gender, ethnic group and economic class. Gilead funds organizations that work in this therapeutic area to:

• Improve individuals’ health literacy, enabling them to make informed health decisions
• Educate healthcare providers on identification, screening and diagnosis
• Improve access to treatment by overcoming financial and other obstacles

NOTE: There are no formal application deadlines. The Foundation’s Board of Trustees reviews all applications at its quarterly meetings. Applicants should be prepared to wait several weeks or months for a decision.

About

Robert Mapplethorpe established the Robert Mapplethorpe Foundation on May 27, 1988, the year before his death, to protect his work, to advance his creative vision and to promote the causes he cared about. Serving as the first president of its board of trustees, he established two mandates: to promote photography as an art form in order to achieve its recognition and respect at the same level as painting and sculpture; and to support HIV/AIDS medical research. In keeping with Mapplethorpe's wishes, The Robert Mapplethorpe Foundation continues to support photography programming at both major museums as well as small institutions for exhibitions, acquisitions, and publications.

In 1993, the Foundation provided an historic gift to the Solomon R. Guggenheim Foundation to create the named Robert Mapplethorpe Gallery and to inaugurate the Guggenheim Museum's photography program. In addition to its financial component, the Foundation made a gift of more than 200 of the artist’s works, selected by the Museum.

The Foundation subsequently awarded three major gifts supporting photography programs which resulted in galleries or facilities permanently named for Robert Mapplethorpe—at the Whitney Museum of American Art, the Hessel Museum of Art at Bard College, in Annandale-on-Hudson, NY, and the National Portrait Gallery, part of the National Galleries of Scotland in Edinburgh. In addition to the Guggenheim Museum, significant public collections of Mapplethorpe’s work may be found in the Artist Rooms Collection jointly owned by the Tate Modern, London and the National Galleries of Scotland; at the Museum of Modern Art, New York; the Hessel Museum of Art; and the Kinsey Institute at Indiana University.

In 2011, the Mapplethorpe Foundation donated its archive to the Getty Research Institute and gave an encyclopedic collection of artworks to the J. Paul Getty Museum in partnership with the Los Angeles County Museum of Art. This gift established a comprehensive archive and collection available to scholars.

In its early years, the Foundation prioritized its focus on HIV and AIDS medical research. It created important medical facilities and programs, including the Robert Mapplethorpe Laboratory for AIDS Research at Harvard Medical School in Boston, the Robert Mapplethorpe Residential Treatment Facility at Beth Israel Medical Center in New York, and the Robert Mapplethorpe Center for HIV Research at St. Vincent's Hospital, New York. The Foundation provided substantial financial support to the American Foundation for AIDS Research (amfAR). The Foundation continues to support research initiatives and has provided funds to amfAR, distinguished institutions such as the Rockefeller University, and community-based experimental treatment organizations, including the AIDS Community Research Initiative of America (ACRIA).

The Foundation is dedicated to protecting and expanding Mapplethorpe’s artistic legacy by encouraging museum exhibitions internationally. It publishes books and places his artworks from its considerable inventory in important public and private collections around the world.

Photography Grant

As the beneficiary of Robert Mapplethorpe’s Estate, the Foundation has made contributions in the form of artworks or gifts of money to qualifying applicants. In the appropriate circumstance, the Foundation will also assist independent curators in developing interesting photography exhibitions.

NOTE: Proposals are accepted on a rolling basis. Applicants are encouraged to submit proposals by July 7, 2022. For those requesting support for special events, proposals must be received at least six weeks prior to the scheduled event.

Positive Action Community Grants

ViiV Healthcare was established to take an innovative approach to the challenge of HIV—and we do. It’s who we are. An innovative approach means we go beyond developing new medicines—we know it takes more to end the epidemic.

Through a combination of community-focused approaches that include deep listening, grantmaking, community engagement, shared learning, and cultural arts programs, we ensure that the voices of the HIV community inform everything we do.

Focus

Our approach to giving has always been about more than money. We Listen. Seeking insights and understanding to foster collaboration and action. We Activate new initiatives and fund community projects where there are the greatest disparities, while connecting individuals and organizations to strengthen networks and services. We Amplify. Sharing insights to illuminate bright spots and drive community solutions. We Sustain. Strengthening leaders, organizations, and communities to build and expand on the momentum of effective work. Through this approach we focus our funding and collaborations on community organizations that are prioritizing work in three key focus areas:

Networks

Strengthen supportive networks for people living with an impacted by HIV and those who serve them

Linkage & Engagement

Support navigation and programs that help link, re-link, and engage people in HIV prevention, treatment, and care

Advocacy

Amplify the efforts of people living with and impacted by HIV to advocate for themselves, strengthen leadership, insights, and culture activities that reduce stigma, and fuel community responses.

Funding

ViiV Healthcare’s Positive Action Community Grants (PACG) initiative is currently requesting proposals to support:

• The health and well-being of people living with HIV through innovative, community-led solutions that address disparities in the epidemic, and;
• Strong prevention infrastructure for communities of color, fueling new ways to reach and engage people in HIV prevention, shift the narrative around risk, and fuel networks that help disrupt disparities in HIV prevention.

Organizations applying to Positive Action Community Grants may request funding in the following three categories:

• General operating support for core support and mission-driven community-based work.
• Special events sponsorships for conferences and events that foster networks, create awareness, and amplify the voices of people living with HIV and AIDS.
• Project support for organizations implementing innovative projects within ViiV Healthcare’s focus areas: linkage to care, networks of support, and advocacy. ViiV Healthcare is particularly interested in efforts that operate at the intersection of HIV, stigma, and other social determinants of health in the following ways:
  • Expanding harm reduction services and advocacy to successfully engage people who use drugs in care, and support their families and communities;
  • The decriminalization of HIV at the local and national level;
  • Increasing access to quality and culturally responsive sexual health education;
  • Activating arts and culture as a tool for community engagement, connection, and building empathy;
  • Increasing access to and awareness of the mental health needs of people living with or vulnerable to HIV.

Mission

AIDS United’s mission is to end the HIV epidemic in the United States.

In the ongoing work for social justice and true equity, ending the HIV epidemic in the United States is our chosen role. We’ve seen firsthand how the intersectionality of social injustice, discrimination and health care disparity impacts those living with HIV, and we believe alleviating this struggle is a pivotal step toward our national well-being.

Vision

AIDS United envisions a time when all people, governments and organizations commit to ending the epidemic and strengthening the health, well-being, and human rights of everyone impacted by HIV.

We envision a world with an ambitiously holistic definition of human rights.

We must expand the conversation about those of us impacted by HIV to account for and address the intersectionality of health disparities, social injustice, white supremacy, racism, sexism, homophobia, transphobia and every kind of inequity.

Harm Reduction Futures Fund

The Harm Reduction Futures Fund (formerly the Syringe Access Fund) is a collaborative grantmaking initiative that seeks to reduce the health, psychosocial, and socioeconomic disparities experienced by people who use drugs (PWUD). The Harm Reduction Futures Fund invests in evidence-based and community-driven approaches to prevent the transmission of both HIV and viral hepatitis, reduce injection-related injuries, increase overdose prevention and reversal efforts, and connect people who use drugs to comprehensive prevention, treatment, and support services.

The Harm Reduction Futures Fund will award grants this Round to three kinds of organizations:

• syringe services programs providing direct services,
• harm reduction organizations supporting multiple syringe service programs providing direct services, and
• harm reduction organizations conducting community advocacy activities focused on legalizing or strengthening syringe services programs and other health interventions for PWUD at the local, state, or federal levels.

Purpose

The primary goal of the Harm Reduction Futures Fund is to provide core support for programs that demonstrate:

• an ability to provide high quality syringe and other drug user health services to one or more identified communities, and/or
• an ability to conduct local-, statewide-, or national-level policy advocacy initiatives that demonstrate concrete objectives and activities to expand access to community-based syringe distribution.

The Harm Reduction Futures Fund seeks to identify and support organizations across intersecting movements to enhance and coordinate services for people who use drugs. It supports and funds organizations that are led by and/or meaningfully involve and serve networks of people who use drugs, including in the design, delivery, and evaluation of services. In Round 14, the Harm Reduction Futures Fund will prioritize support for programs that are led by and serve Black, Indigenous, and other People of Color (BIPOC), as well as those in jurisdictions of high need and low resources. Other compelling factors may include the leadership of current or former sex workers; prevalence of HIV, viral hepatitis, and other blood-borne pathogens in a community; injection drug use prevalence; opioid use; overdose incidence; availability of local funding; and areas in which policy improvement can have local, state, and/or national impact.

Funding

AIDS United expects to provide one-year cash grants to a total cohort of 12 to 19 organizations.

• Direct Service organizations are invited to submit proposals for $10,000 to $25,000 for one year.
  • AU anticipates 5-10 programs will receive funding
• Multi-Program Support organizations are invited to submit proposals for $25,000 to $40,000 for one year.
  • AU anticipates 1 program will receive funding
• Harm Reduction organizations with Advocacy projects are invited to submit proposals for $10,000 to $25,000 for one year.
  • AU anticipates 1 program will receive funding

Through this funding opportunity announcement, the National Cancer Institute (NCI) intends to focus on the biological interactions of cancer health disparities in people living with HIV (PLWH) from underrepresented minority groups through basic mechanistic or translational studies to investigate how HIV interacts with health disparities to promote both non-AIDS and AIDS-defining cancer initiation, progression, and the resulting pathogenic disease sequelae.

2023 Housing Opportunities for Persons With AIDS (HOPWA) Competitive Grant: Housing Interventions (HINT) to End the HIV Epidemic

This funding will provide communities an opportunity to create and implement new projects that align with initiatives aimed at ending the HIV epidemic, and elevate housing as an effective structural intervention in ending the epidemic. HUD is seeking projects with exemplary and innovative qualities, including incorporation of Housing First principles, community-level coordination, data collection with emphasis on stable housing and positive health outcomes, the use of cultural humility in providing housing and services, and a systemic approach to advance equity in underserved communities that can serve as a national place-based model. Each project must be designed for the Grantee to achieve the following six required project objectives:

• Implement and document a low-barrier model using Housing First principles to provide housing and services to low-income people with HIV and their families that is innovative and replicable in other similar localities or nationally;
• Increase alignment with new or existing local initiatives or strategies to end the HIV epidemic by elevating housing as an effective structural intervention;
• Improve use of available community resources and coordination among local housing and service providers;
• Increase the amount of quality data collected and used for data-driven decision making with an emphasis on stable housing, positive health outcomes, and equity;
• Assess and document replicable practices that ensure equitable access and cultural humility in providing housing and services for populations of people with HIV experiencing service gaps; and
• Prioritize sustainable, effective, and equitable approaches to providing housing and services to people with HIV and their families that can be continued past the funded project’s period of performance.

Each successful applicant under this NOFO will receive a one-time, non-renewable grant to fund housing assistance and supportive services for eligible individuals and families, coordination and planning activities, and grants management and administration. Reporting requirements under this NOFO are more comprehensive than traditional HOPWA program reporting. Grantees will be required to collect client-level data to produce a programmatic HIV Housing Care Continuum Model at the end of each operating year. At the end of the grant period of performance, each grantee must also develop a SPNS Grant Model, consisting of promising practices for and lessons learned in using housing as a structural intervention to end the HIV epidemic. Each SPNS Grant Model will be shared with the public, and lessons learned through these grantee efforts will help inform national and community policy and actions.

About Us

Kent Richard Hofmann (1946-1988) was an Atlanta-based architect and philanthropist. Established the Kent Richard Hofmann Foundation, initially for general philanthropic and educational purposes. As an early AIDS activist, he worked to heighten public awareness as the crisis increased. Since Hofmann's death in 1988, in keeping with his wishes, the Foundation has been dedicated exclusively to HIV and AIDS support.

Grantmaking

The Kent Richard Hofmann Foundation is a small, private foundation dedicated to the fight against HIV and AIDS.

Grants are made semi-annually, to community-based organizations, in support of:

• Care and direct services
• Education
• Research

Grants are made to support developing or established programs, with emphasis on direct benefit to clients or target audiences. Requests from throughout the US are considered, with a particular interest in smaller communities and rural areas.

Previous requests receiving serious consideration have included:

• Requests from locations with a scarcity of available funding;
• Requests for seed money for new projects, programs, or structures;
• Innovative ideas for meeting standard needs.